Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K211854
    Device Name
    VITA Akzent LC
    Date Cleared
    2021-11-22

    (159 days)

    Product Code
    Regulation Number
    872.3310
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K133836

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    VITA AKZENT LC Indication range:

    • Restorations made of hybrid ceramic
    • · Restorations made of light-curing veneering material
    • · Restorations made of CAD/CAM composites
    • · Prefabricated Teeth
    • · Denture bases
    Device Description

    VITA AKZENT LC is a light-curing methacrylatebased stain/ glaze system for extraoral surface characterization of dental restorations made of hybrid ceramic, resin veneering materials, CAD/CAM composites, prefabricated teeth and denture base resins. It can also be used for internal characterization with the layering technique of veneering composites.

    AI/ML Overview

    The document describes the VITA Akzent® LC, a light-curing methacrylate-based stain/glaze system for extraoral surface characterization of dental restorations. The acceptance criteria and the study proving the device meets these criteria are outlined in the "Non-Clinical Performance Testing" and "Biocompatibility" sections.

    1. Table of Acceptance Criteria and Reported Device Performance:

    Acceptance CriteriaReported Device Performance
    Biocompatibility: Conformance to ISO 10993-1:2009 (Biological evaluation of medical devices) and ISO 7405:2004 (Dentistry – Evaluation of biocompatibility of medical devices).A biocompatibility assessment was performed on VITA Akzent® AC in accordance with ISO 10993-1:2009 and ISO 7405:2008. The assessment supports that VITA Akzent® LC is biocompatible and concludes that the device is substantially equivalent to the predicate device in terms of biocompatibility.
    Performance: General safety and effectiveness for its intended use as a coating material for resin fillings."Performance and biocompatibility testing prove that the subject device, in a liquid form, does not impact the safety and effectiveness of the product... The adhesion performance testing conducted against the reference device, shows a more favorable efficacy during bench testing."

    2. Sample Size Used for the Test Set and Data Provenance:

    The document does not specify a distinct "test set" in the traditional sense of a clinical study with human subjects. The evaluation was primarily based on non-clinical performance testing and biocompatibility assessment.

    • For biocompatibility, the testing was conducted in-vitro/non-clinical based on recognized international standards. Specific sample sizes for these tests (e.g., number of specimens tested for cytotoxicity, irritation, etc.) are not explicitly stated in this summary.
    • For adhesion performance, "bench testing" was conducted. The sample size for this testing is not explicitly stated.
    • The data provenance is not explicitly stated but is presumed to be from laboratory testing as per the cited ISO standards.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications:

    This information is not applicable and not provided in the document because the assessment was based on non-clinical (laboratory) testing and established international standards for biocompatibility and material performance, rather than clinical efficacy studies requiring expert evaluation of patient data.

    4. Adjudication Method for the Test Set:

    This information is not applicable and not provided as the evaluation was based on objective laboratory testing against established standards, not human interpretation of results requiring adjudication.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done:

    No, a Multi Reader Multi Case (MRMC) comparative effectiveness study was not done. The document explicitly states: "No human clinical testing was performed to support the substantial equivalence of VITA Akzent® AC."

    6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done:

    This concept is not applicable to this device. VITA Akzent® LC is a material (a stain/glaze system), not an algorithm or an AI-powered diagnostic tool. Its performance is determined by its physical and chemical properties as evaluated through non-clinical laboratory tests.

    7. The Type of Ground Truth Used:

    The ground truth for demonstrating the device's performance relies on:

    • Established international standards: ISO 10993-1 (Biological evaluation of medical devices) and ISO 7405 (Dentistry – Evaluation of biocompatibility of medical devices).
    • Bench test results: Specifically, "adhesion performance testing" against a reference device.
    • Material composition equivalence: Comparison of the chemical composition to predicate devices.

    8. The Sample Size for the Training Set:

    This information is not applicable and not provided. As VITA Akzent® LC is a material and not an AI/ML algorithm, there is no "training set" in the conventional sense. Its development would likely involve
    iterative formulation and testing, but not machine learning training.

    9. How the Ground Truth for the Training Set Was Established:

    This information is not applicable and not provided, as there is no "training set" for this type of device. The formulation and development of the material are based on scientific principles of polymer chemistry and dental material science, combined with performance testing.

    Ask a Question

    Ask a specific question about this device

    K Number
    K153325
    Device Name
    Gradia Plus
    Manufacturer
    Date Cleared
    2016-07-12

    (236 days)

    Product Code
    Regulation Number
    872.3690
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K033808, K123631, K133836

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use
    1. Crown and Bridgework (with metal backing)
    2. Metal free restorations: Jacket Crowns, Inlays, Onlays and Laminated Veneers
    3. Implant superstructures
    4. Reproduction of gum tissue for crown restorations
    Device Description

    GRADIA PLUS is a dental composite consisting of cross-linked polymeric material reinforced by a dispersion of filler particles bonded to the resin matrix. The product contains a photo initiator to allow for curing/conversion. The end result is a conversion from a paste to a hard solid material. GRADIA PLUS is composed of 4 types of pastes, such as Opaque paste, Gum shade paste and Lustre paint. Opaque paste is used for masking the metal color. Body paste has two different consistencies. Paste HB and Paste LB. Both pastes can be used for creating several types of anterior or posterior restorations. There are several shades for dentin shade, Enamel shade and effect shade. The dentin layers have an enhanced brightness and masking ability that adjusts the opalescence of the composites. This gives a bright color tone in the oral cavity and eliminates unnatural translucency at the incisal edge. In addition, it has several red colors as a Gum shade paste with different transparency and color tone for reproducing of gingival tissue over crown. Lustre Paint is used for staining, characterizing and coating. The device is used for crown and bridgework with metal backing, jacket crowns, inlays, veneers, implant super structures and reproduction of gum tissue for crown restorations. In particular, Gradia Plus is intended to fabricate the tertiary element/exostructure of the implant superstructure, such as crown and bridges. GRADIA PLUS is filled in a syringe and is available in 73 shades.

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and study information for "GRADIA PLUS":

    The document is a 510(k) premarket notification clearance letter from the FDA to GC America Inc. for their dental composite device, GRADIA PLUS. It primarily focuses on establishing substantial equivalence to predicate devices, rather than an independent clinical study demonstrating device performance against specific disease-related acceptance criteria.

    Key Observation: This document describes a material science device (dental composite) and its bench testing to ensure it meets material property standards (ISO). It is not a diagnostic AI device, and therefore the typical questions about ground truth, expert readers, MRMC studies, or standalone algorithm performance are not applicable in this context. The "acceptance criteria" here refer to conformance with established material standards and the "study" is a series of bench tests.


    Acceptance Criteria and Device Performance

    Acceptance Criteria (ISO 10477:2004 and company standards)Reported Device Performance
    Sensitivity to ambient lightConforms to required specifications
    Depth of cureConforms to required specifications
    Surface finishConforms to required specifications
    Flexural strengthConforms to required specifications (also compared to predicates for equivalence)
    Water sorptionConforms to required specifications (also compared to predicates for equivalence)
    SolubilityConforms to required specifications (also compared to predicates for equivalence)
    Shade consistencyConforms to required specifications
    Color stabilityConforms to required specifications
    Overall Stability of Materials in Oral EnvironmentShows equivalence in flexural strength, water sorption, and solubility (compared to predicates)

    Note: The document states, "It is confirmed that the device conforms to the required specifications of ISO 10477:2004 and company standard are suitable for its intended use." It also mentions "shows equivalence in flexural strength, water sorption and solubility" when comparing to predicate devices. Specific quantitative values for the reported device performance are not provided in this document, only a statement of conformance.


    Study Details (as inferable from the document)

    • 1. Sample size used for the test set and the data provenance:

      • Sample Size: Not explicitly stated. The testing would involve preparing multiple samples of the GRADIA PLUS material for each physical property test (e.g., multiple specimens for flexural strength, multiple for water sorption). The number of replicates for each test would typically follow ISO standard guidelines.
      • Data Provenance: The tests are "bench tests" performed by GC America Inc. ("company standard"). The country of origin of the data is implicitly the location where GC America Inc. conducted its R&D and testing (Alsip, Illinois, USA, as per their address). The data is prospective in the sense that it was generated for the purpose of validating the new device, but it is material property testing, not clinical trial data on human subjects.
    • 2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • Not Applicable. This is not a study requiring human expert interpretation for "ground truth" as it is material science testing. The "ground truth" is derived from physical measurements against established ISO standards.
    • 3. Adjudication method for the test set:

      • Not Applicable. No human adjudication process is described or implied for these material property tests.
    • 4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • Not Applicable. This is a dental material, not an AI diagnostic device. No human-in-the-loop or MRMC study was conducted or is relevant.
    • 5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

      • Not Applicable. This is a dental material, not an AI algorithm. No standalone algorithm performance was assessed.
    • 6. The type of ground truth used:

      • The "ground truth" for the acceptance criteria is defined by established international standards (ISO 10477:2004) and internal company specifications for dental resin materials. This involves precise physical and chemical measurements rather than clinical ground truth (e.g., pathology, outcomes data, or expert consensus) relevant to diagnostic devices.
    • 7. The sample size for the training set:

      • Not Applicable. This device is a dental composite material, not a machine learning model. There is no concept of a "training set" in this context.
    • 8. How the ground truth for the training set was established:

      • Not Applicable. As there is no training set, this question is irrelevant.

    Summary regarding the device type:

    The GRADIA PLUS is a dental composite material used for restorations like crowns, bridges, inlays, onlays, and veneers, as well as gum tissue reproduction. The "study" referenced in the document is a series of performance bench tests designed to confirm that the material properties of the device conform to relevant ISO standards (ISO 10477:2004) and internal company specifications. The FDA's clearance is based on the determination of substantial equivalence to existing predicate devices, meaning it has similar indications for use, fundamental scientific technology, and performance characteristics (as demonstrated by these bench tests). The questions provided are primarily geared towards AI/ML diagnostic devices, which operate under a very different regulatory and validation framework than a material science product like this dental composite.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1